Filter
3408
Filtered Results: 3408
Text search:
national
drug
authority
Featured
Recommendations
315
New Publications
974
Language
Document type
No document type
2024
Studies & Reports
532
Guidelines
453
Manuals
165
Strategic & Response Plan
134
Fact sheets
34
Training Material
33
Situation Updates
19
Resource Platforms
4
Infographics
4
Brochures
3
Online Courses
3
Countries / Regions
India
175
Global
118
Kenya
103
Ethiopia
94
Uganda
93
Western and Central Europe
89
South Africa
68
Nigeria
67
Liberia
65
Ghana
62
Tanzania
58
Sierra Leone
55
Latin America and the Carribbean
54
Myanmar / Burma
51
Nepal
50
Zambia
50
Malawi
49
Bangladesh
49
Rwanda
41
Africa
40
Eastern Europe
36
Ukraine
35
Zimbabwe
31
Cambodia
30
South–East Asia Region
30
Namibia
29
Asia
28
Philippines
26
Lesotho
22
Congo, Democratic Republic of
19
Botswana
18
Syria
15
Indonesia
14
Eastern Europe and Central Asia
13
Senegal
12
Mozambique
12
South Sudan
12
Eswatini/ Swaziland
12
Venezuela
11
Burkina Faso
10
Russia
10
Haiti
9
Germany
9
East and Southern Africa
9
Brazil
9
Colombia
8
Albania
8
Guinea
8
West and Central Africa
8
Middle East and North Africa
8
Vietnam
8
Pakistan
8
Laos
7
USA
7
Tajikistan
6
Thailand
6
China
6
Cameroon
6
Afghanistan
6
Western Pacific Region
6
Georgia
6
North America
5
Moldova
5
Sri Lanka
5
Sudan
5
Central African Republic
5
North Macedonia
4
Mexico
4
Jordan
4
Yemen
4
Iraq
4
Turkey
3
Benin
3
Iran
3
Fiji
3
Jamaica
3
Lebanon
3
Papua New Guinea
3
Palestine
3
Mali
3
Libya
3
Somalia
3
Timor Leste/ East Timor
2
El Salvador
2
Serbia
2
Chile
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Mongolia
2
Armenia
2
Hungary
2
Saudi Arabia
2
United Kingdom
2
Portugal
2
Bolivia
2
Argentina
2
Poland
2
Bhutan
2
North Korea
1
Switzerland
1
Australia
1
Kazakhstan
1
Canada
1
Estonia
1
Qatar
1
Bulgaria
1
Italy
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1279
Clinical Guidelines
328
Public Health
200
Women & Child Health
144
Key Resources
131
Pharmacy & Technologies
56
Capacity Building
48
Toolboxes
HIV
360
TB
315
Mental Health
283
AMR
206
COVID-19
149
Pharmacy
141
NTDs
118
Rapid Response
80
Caregiver
66
Ebola & Marburg
58
Planetary Health
51
NCDs
50
Refugee
49
Conflict
45
Global Health Education
39
Disability
33
Health Financing Toolbox
20
Polio
18
Zika
16
Natural Hazards
15
Specific Hazards
14
Cholera
14
Malaria
11
Social Ethics
5
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report and background documents!
The report demonstrates that the current system—at both national and international levels— was not adequate to protect people from COVID-19. The time it t...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement...
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Practical actions in cities to strengthen preparedness for the COVID-19 pandemic and beyond
recommended
This document accompanies the interim guidance on “Strengthening Preparedness for COVID-19 in cities and urban settings”. It provides local authorities, leaders and policy-makers in cities with a checklist tool to ensure that key areas have been covered. An excel version that local authorities m...
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
The curriculum, which complements the national pediatric ART training, was finalized in 2011 and was subsequently implemented nationally. The training curriculum includes a 15-module Trainer Manual, a Participant Manual, and accompanying PowerPoint slides.
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog...
